Volume | 2,650,031 |
|
|||||
News | - | ||||||
Day High | 0.0003 | Low High |
|||||
Day Low | 0.0002 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
RushNet Inc (PK) | RSHN | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.00025 | 0.0002 | 0.0003 | 0.0003 | 0.0003 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6 | 2,650,031 | $ 0.000246 | $ 651 | - | 0.0001 - 0.0009 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:45:20 | 31 | $ 0.00026 | USD |
RushNet Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 8.58B | - | 6.9M | -665k | -0.00 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
RushNet (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSHN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0003 | 0.0003 | 0.0002 | 0.0002963 | 637,819 | 0.00 | 0.00% |
1 Month | 0.0003 | 0.0004 | 0.0002 | 0.0002739 | 8,464,694 | 0.00 | 0.00% |
3 Months | 0.0003 | 0.0006 | 0.0002 | 0.0003721 | 13,186,354 | 0.00 | 0.00% |
6 Months | 0.0002 | 0.0006 | 0.0001 | 0.000319 | 23,603,126 | 0.0001 | 50.00% |
1 Year | 0.0004 | 0.0009 | 0.0001 | 0.0003219 | 18,227,130 | -0.0001 | -25.00% |
3 Years | 0.0007 | 0.0249 | 0.0001 | 0.0047798 | 70,093,874 | -0.0004 | -57.14% |
5 Years | 0.0015 | 0.0249 | 0.0001 | 0.0038282 | 56,207,123 | -0.0012 | -80.00% |
RushNet (PK) Description
heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states, and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education. |